30-Year Industry Veteran to Assist Adult Stem Cell Company in Strategic Positioning and Alliance Formation SAN DIEGO, CA--(Marketwire -01/24/12)- Medistem Inc. (Pinksheets: MEDS.PK - News) announced today appointment of Dr. Alan Lewis to the company's advisory board. Dr. Lewis spent 15 years at the pharmaceutical company Wyeth-Ayerst, where he was Vice … [Read more...]
Dr. Alan Lewis, Previous CEO of Juvenile Diabetes Research Foundation, Joins Medistem Advisory Board
January 24, 2012 By Leave a Comment
Medistem and Licensee ERCell Receive Russian Regulatory Approval for the RECOVER-ERC Trial
January 23, 2012 By Leave a Comment
Dose Escalating, Double Blind, Placebo Controlled Universal Donor Stem Cell Trial for No-Option Heart Failure Patients to Be Conducted at Backulev Center SAN DIEGO, CA--(Marketwire -01/23/12)- Medistem Inc. (Pinksheets: MEDS.PK - News) together with its Russian Licensee, ERCell LLC, have received approval to initiate the first double-blind, placebo controlled … [Read more...]
Medistem Inc. Annual Letter to Shareholders
December 31, 2011 By 2 Comments
SAN DIEGO, CA--(Marketwire -12/31/11)- Medistem Inc. (Pinksheets: MEDS.PK - News) today issues the following letter to shareholders. Dear Fellow Shareholders, The last year has been remarkable for Medistem: new investors, new collaborators, and an FDA approval. The FDA approval is for a 15 patient study investigating the safety and therapeutic effects of … [Read more...]
Entest BioMedical and RenovoCyte Begin Pilot Study of “Universal Donor” Stem Cell Treatment of Canine Osteoarthritis
November 18, 2011 By Leave a Comment
SAN DIEGO, CA--(Marketwire -11/18/11)- Entest BioMedical Inc. (OTCQB: ENTB.PK - News) (Pinksheets: ENTB.PK - News) and RenovoCyte LLC today announced the treatment of the first canine patient of a 10 dog pilot study utilizing Canine Endometrial Regenerative Cells (CERC) licensed from Medistem Inc. (Pinksheets: MEDS.PK - News) in the treatment of canine … [Read more...]
Yale Endometrial Stem Cell Expert Joins Medistem’s Scientific Advisory Board
November 8, 2011 By 1 Comment
SAN DIEGO, CA--(Marketwire -11/08/11)- Medistem Inc. (Pinksheets: MEDS.PK - News) announced today the appointment of Dr. Hugh S. Taylor to its Scientific Advisory Board. Dr. Taylor is the first scientist to identify the bone marrow origin of endometrial tissue, and performed independent experiments demonstrating that endometrial stem cells are capable of treating … [Read more...]
Entest BioMedical Signs Agreement With RenovoCyte and Medistem for Pilot Study Using Universal Donor Stem Cells in Treatment of Dog Osteoarthritis
October 24, 2011 By 3 Comments
SAN DIEGO, CA -- (Marketwire -10/24/11)- Entest BioMedical (OTCQB: ENTB.PK - News) (Pinksheets: ENTB.PK - News) announced today that, together with RenovoCyte LLC and Medistem Inc. (Pinksheets: MEDS.PK - News), it plans to initiate a 10 dog pilot study using Canine Endometrial Regenerative Cells (CERC) in the treatment of osteoarthritis at the McDonald Animal … [Read more...]
Medistem Collaborates on Nanoparticle siRNA Finding for Treatment of Ischemic Conditions
October 20, 2011 By Leave a Comment
Adult Stem Cell Company Publishes With Canadian Scientists on Finding That Could Lead to Improved Transplantation Results SAN DIEGO CA--(Marketwire - Oct 20, 2011) - Medistem Inc. (PINKSHEETS: MEDS), a clinical stage adult stem cell company, reported today on a publication of a novel method of preventing transplant-associated ischemic liver injury using a … [Read more...]
Medistem to Discuss Immunological Aspects of Endometrial Regenerative Cells at Providence Multiple Sclerosis Center
September 28, 2011 By Leave a Comment
SAN DIEGO, CA, Sep 28, 2011 (MARKETWIRE via COMTEX) -- Medistem Inc. (pinksheets:MEDS) announced today that its Chief Executive Officer, Thomas Ichim, will be giving an academic lecture at the Providence Multiple Sclerosis Center, in Portland, Oregon on Sept 28th, entitled "Stem Cell Transplants for Multiple Sclerosis: Time to Focus on the Mesenchymals?" "We … [Read more...]
Medistem – Coming Of Age?
September 23, 2011 By Leave a Comment
Biotechnology company Medistem Inc. (MEDS.PK: News ) has hit a milestone , following regulatory approval to begin a clinical trial in the U.S. with its lead product candidate endometrial regenerative cell stem cell product. The endometrial regenerative cell, or ERC for short, is a "universal donor" stem cell derived from the menstrual blood that possesses the … [Read more...]
Medistem Receives FDA Approval to Begin Clinical Trial in USA With ERC Stem Cells
September 22, 2011 By Leave a Comment
SAN DIEGO, CA -- (Marketwire -09/22/11)- Medistem Inc. (Pinksheets: MEDS.PK - News) announced today approval from the FDA to initiate a dose-escalating clinical trial in patients with critical limb ischemia using its Endometrial Regenerative Cell (ERC) stem cell product. This approval puts Medistem in a small list of companies that have Federal permission to … [Read more...]